Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
Canada (Primary) | PRIMARYCAN | Univ | 1,720 | 2,814,283 | 0.32% | 1.35% | 5.06% | 8.79% | 18.86% | 22.41% |
Healthcare | HEALTHCARE | Sector | 73 | 9,813 | 1.07% | -0.02% | 1.39% | 3.38% | 14.90% | 13.61% |
Biopharmaceuticals | BIOPHARMA | SubSec | 22 | 2,257 | 1.47% | 0.59% | 7.68% | 14.02% | 26.51% | -0.69% |
System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 10 | 1,139 | 2.30% | 1.45% | 12.03% | 19.41% | 47.43% | 22.89% |
Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
Musculoskeletal System Biopharmaceuticals | MUSCULOSKELETAL | SubInd | 1 | 191 | 0.27% | -0.67% | -0.41% | 38.01% | 50.72% | 50.72% |
Cardiovascular System Biopharmaceuticals | CARDIOVASCULAR | SubInd | 2 | 32 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Digestive System Biopharmaceuticals | DIGESTIVE | SubInd | 1 | 19 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Endocrinology and Metabolism Biopharmaceuticals | ENDOCRINOLOGY | SubInd | 2 | 197 | 0.67% | 1.80% | 2.49% | 29.06% | 67.78% | 67.78% |
S&P/TSX Capped Composite | XIC:CANXIC:CAN | Benchmark | 211 | 3,391,125 | 0.52% | 2.24% | 4.28% | 10.63% | 19.01% | 30.00% |
System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 10 | 1,139 | 2.30% | 1.45% | 12.03% | 19.41% | 47.43% | 22.89% |
Dermatology Biopharmaceuticals | DERMATOLOGY | SubInd | 1 | 294 | 1.20% | 0.56% | 18.32% | 23.23% | 41.15% | 5.95% |
Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 3 | 407 | 7.39% | 4.71% | 26.00% | -3.08% | 8.00% | 27.09% |
* Colors indicate performance relative to the benchmark.